| 作者 |
 下星期到上海，希望晚上拜见地方上的大佬们。 |
 |
| 所跟贴 |
下星期到上海，希望晚上拜见地方上的大佬们。 -- tutu - (0 Byte) 2005-8-13 周六, 09:52 (2342 reads) |
ceo/cfo
[博客]
[个人文集]
头衔: 海归中将
声望: 院士
性别: 
加入时间: 2004/11/05
文章: 12941
海归分: 491638
|
|
|
作者：ceo/cfo 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
month?
Just came across this article. Way to go! first to learn how to make money, then to learn how to give money away:
Gift of the Week
Doctor Writes Rx
For $105 Million
By ELIZABETH BERNSTEIN
Staff Reporter of THE WALL STREET JOURNAL
August 12, 2005; Page W1
A doctor who helped invent a successful anti-inflammatory drug has donated an estimated $105 million to the New York University School of Medicine -- one of the largest gifts ever made to a U.S. university.
Dr. Jan T. Vilcek, an NYU professor of microbiology, has given the school a percentage of future royalties he receives from sales of Remicade. The drug treats symptoms of rheumatoid arthritis and Crohn's disease, an inflammation of the digestive tract.
The gift will support both research and education programs. Some of it is designated for the microbiology department, which will establish two additional endowed professorships and several graduate and post-doctoral fellowships. The department will also get an 8,000-square-foot laboratory for the study of infectious diseases, located in the school's new research building, which is due to open in February. The otolaryngology department will get money to hire new faculty and to pay for research. (Several years ago, doctors in the department successfully treated Dr. Vilcek's wife, Marica, for hearing and balance problems.) The gift also will support other areas of scientific research, including cell biology, genetics and genomics.
NYU School of Medicine received an estimated $105 million.
Under Dr. Vilcek's arrangement with NYU, the gift has been divided into three portions. The first part consists of ongoing quarterly payments to the school from the drug's maker, Centocor, a division of Johnson & Johnson. To date, NYU has received approximately $5 million under this component of the gift. The other two portions involve the sales of rights to future royalties. Dr. Vilcek assigned these rights to two trusts, which in turn sold them to a company that buys these rights. The proceeds of the sales -- one of which netted about $20 million and the other about $46 million -- will eventually benefit NYU.
The $105 million valuation of the gift is based on expected revenue from the drug, whose patent is set to expire in 2018. If future sales are stronger than expected, the gift could wind up exceeding that amount. More than 600,000 people world-wide have taken Remicade since its approval by the Food and Drug Administration in 1998, according to Centocor. Last year, sales of the drug reached $2.1 billion. Centocor says sales are up 22% compared to the same period a year ago. (Because the drug was developed at NYU, the school already gets its own royalties on Remicade sales; it took in $63 million last year.) Recently, questions have been raised about Remicade's marketing and side effects. In February, the FDA warned Centocor that promotional materials contained unsubstantiated effectiveness claims and failed to include information about potential risks. In 2004, the company sent a letter to health professionals warning that the drug, like others in its class, could have serious and sometimes fatal side effects, including an increased risk of lymphoma.
Dr. Vilcek, 72 years old, was born and educated in Czechoslovakia but defected in the mid-'60s, arriving in the U.S. in 1965. He has spent 40 years on the NYU medical-school faculty studying proteins that regulate the immune system. In 1989, he and a colleague created an antibody that successfully blocks some types of inflammation. The pair then worked with Centocor to develop Remicade.
Dr. Vilcek says he made the gift to NYU because the university has long supported his work and he wants to help the school attract future scientists. "I feel that NYU gave me the opportunity to prove myself," he says. The university says it will name several programs and laboratories after Dr. Vilcek and his wife. They include the Jan T. Vilcek Professorship in the Department of Microbiology, the Jan T. and Marica F. Vilcek Laboratory Floor for Research in Microbial Pathogenesis and the Marica F. Vilcek Research Laboratories in the otolaryngology department.
作者：ceo/cfo 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
| 相关主题 |
| 这星期广州海归聚会，请想参加的同学说明自己最方便的时间
|
海归论坛 |
2004-7-28 周三, 20:38 |
| [贴图]腌制一个星期的酱鸡，酱肉
|
风情美食 |
2010-12-12 周日, 12:53 |
| 香港吃喝玩乐系列：【精彩照片】坐天星小轮过海，看维多利亚港美景（照片在fl...
|
风情茶馆 |
2010-9-02 周四, 22:45 |
| 期市黑幕，希望对大家了解国内期市有帮助
|
海归论坛 |
2006-1-15 周日, 23:54 |
| 猎头们,北京星期天有海归职场聚会,欢迎你们来呀.咱得知己知彼,才能开展工作...
|
海归职场 |
2005-9-02 周五, 19:59 |
| 在这样的星期六早上， 什么都不想做。
|
海归茶馆 |
2005-8-27 周六, 09:52 |
| 明天要去加拿大Fredericton, 星期五回来，匆匆写几句
|
海归论坛 |
2003-11-24 周一, 09:06 |
| zt 老北: 我自己是曾经有户籍优越感的人，可是当我来到国外被人歧视的时候...
|
海归茶馆 |
2005-12-17 周六, 03:17 |
| |
|
|
|
| 返回顶端 |
|
 |
|
-
 下星期到上海，希望晚上拜见地方上的大佬们。 -- tutu - (0 Byte) 2005-8-13 周六, 09:52 (2342 reads) - Those are exiting topics. Wish I could go and meet you. May be next -- ceo/cfo - (4206 Byte) 2005-8-13 周六, 11:04 (389 reads)
|
|
|
|
您不能在本论坛发表新主题, 不能回复主题, 不能编辑自己的文章, 不能删除自己的文章, 不能发表投票, 您 不可以 发表活动帖子在本论坛, 不能添加附件不能下载文件, |
|
|
